Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I)

NCT07587099 NA NOT_YET_RECRUITING

Details

Lead sponsor	Gan Lijun
Phase	NA
Status	NOT_YET_RECRUITING
Enrolment	2170
Start date	Fri May 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Dec 31 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Coronary Heart Disease (CHD)

Interventions

• Drug-coated balloon
• Single antiplatelet therapy (SAPT)
• Dual antiplatelet therapy (DAPT)

Countries

China